查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1545562

全球輔助生殖技術市場

Assisted Reproductive Technology
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 179 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

2030年全球輔助生殖技術市場預計將達276億美元

全球輔助生殖技術市場預估2023年為197億美元，預估至2030年將達276億美元，2023-2030年分析期間複合年成長率為4.9%。體外受精 (IVF) 是本報告分析的細分市場之一，預計複合年成長率為 5.0%，到分析期結束時將達到 220 億美元。在分析期間，冷凍胚胎交換 (FER) 產業的複合年成長率預計為 4.5%。

美國市場預計53億美元，中國預計複合年成長率4.8%

預計2023年美國輔助生殖技術市場規模將達53億美元。中國作為世界第二大經濟體，預計2030年市場規模將達44億美元，2023-2030年分析期間複合年成長率為4.8%。其他值得注意的區域市場包括日本和加拿大，在分析期間預計複合年成長率分別為 4.6% 和 3.8%。在歐洲，德國的複合年成長率預計為 4.0%。

全球輔助生殖科技市場—主要趨勢與促進因素總結

輔助生殖科技如何改變現代不孕症治療？

輔助生殖技術 (ART) 正在徹底改變不孕症治療領域，為數百萬受不孕症困擾的個人和夫妻帶來希望。 ART 包括用於治療不孕症的各種醫療程序，其中體外受精 (IVF) 是最知名和最廣泛使用的方法。這些技術操縱卵子、精子和胚胎來實現懷孕，為面臨自然受孕挑戰的人們開闢了新的可能性。卵細胞質內單一精蟲顯微注射術(ICSI)、胚胎著床前基因檢測 (PGT) 和卵子冷凍等技術的進步極大地提高了成功率並擴大了患者的選擇。隨著 ART 變得越來越複雜，我們不斷突破生殖醫學的界限，提供滿足每位患者獨特需求的個人化解決方案。

哪些技術創新將提高ART的成功率？

技術創新在提高輔助生殖技術的成功率並使這些治療更容易獲得和有效方面發揮關鍵作用。胚胎培養技術的進步，例如使用人工智慧 (AI) 進行延時成像和胚胎品質評估，正在提高選擇最有活力的胚胎進行移植的能力，從而增加成功懷孕的可能性。更複雜的荷爾蒙刺激通訊協定的開發也降低了卵巢過度刺激症候群 (OHSS) 的風險，並改善了接受 IVF 患者的治療結果。此外，冷凍保存的創新，特別是玻璃化技術，顯著提高了冷凍卵子和胚胎的存活率，從而實現更靈活的治療方案和保留生育能力。這些技術進步不僅提高了成功率，而且使 ART 成為更廣泛患者的更可靠選擇，包括患有複雜不孕症的患者和希望推遲分娩的患者。

哪些市場趨勢正在推動輔助生殖技術的採用？

幾個關鍵的市場趨勢正在推動輔助生殖技術的採用，反映了社會對計劃生育態度的變化和生殖醫學的進步。隨著職業優先順序和社會規範的變化，推遲生育的趨勢日益明顯，這增加了對卵子冷凍等生育力保存選擇的需求。此外，同性伴侶和單親父母對輔助生殖技術的認知和接受程度不斷提高，正在擴大不孕症治療的市場。醫療旅遊的成長，特別是在抗愛滋病毒治療較便宜或某些治療較容易取得的國家，也有助於抗愛滋病毒治療服務的全球擴張。此外，隨著越來越多的患者尋求適合其獨特需求和情況的客製化治療計劃，個人化醫療的趨勢正在影響 ART 市場。

推動輔助生殖技術市場成長的因素有哪些？

輔助生殖技術市場的成長是由幾個正在改變不孕症治療格局的因素所推動的。主要影響因素包括因延遲生育、生活方式改變以及影響生殖健康的環境因素導致不孕症盛行率增加。 ART 技術的進步，包括胚胎選擇、冷凍保存和基因檢測的改進，正在提高成功率，並擴大這些治療對更廣泛患者的吸引力。輔助生殖技術服務在新興市場的擴展也促進了市場成長，這些市場中不孕症治療的普及率越來越高。此外，由於生育延遲和計劃生育更加靈活的趨勢，對保留生育能力選擇的需求不斷增加，也推動了輔助生殖技術的採用。隨著這些因素的不斷發展，在技術創新、不斷變化的社會規範以及對有效不孕症治療解決方案日益成長的需求的推動下，輔助生殖技術市場預計將持續成長。

調查企業舉例（共11家）

  • Bloom Fertility Centre
  • Cosmos Biomedical Ltd.
  • Cryolab Ltd.
  • European Sperm Bank ApS
  • Ferring Pharmaceuticals
  • Irvine Scientific
  • Microm UK Ltd
  • ORIGIO A/S
  • Ovascience Inc.
  • Parallabs Limited

目錄

第1章調查方法

第 2 章執行摘要

  • 市場概況
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場展望

第3章市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 其他歐洲國家
  • 亞太地區
  • 其他領域

第4章 比賽

簡介目錄
Product Code: MCP10397

Global Assisted Reproductive Technology Market to Reach US$27.6 Billion by 2030

The global market for Assisted Reproductive Technology estimated at US$19.7 Billion in the year 2023, is expected to reach US$27.6 Billion by 2030, growing at a CAGR of 4.9% over the analysis period 2023-2030. In-Vitro Fertilization (IVF), one of the segments analyzed in the report, is expected to record a 5.0% CAGR and reach US$22.0 Billion by the end of the analysis period. Growth in the Frozen Embryo Replacement (FER) segment is estimated at 4.5% CAGR over the analysis period.

The U.S. Market is Estimated at US$5.3 Billion While China is Forecast to Grow at 4.8% CAGR

The Assisted Reproductive Technology market in the U.S. is estimated at US$5.3 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$4.4 Billion by the year 2030 trailing a CAGR of 4.8% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 4.6% and 3.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.0% CAGR.

Global Assisted Reproductive Technology Market - Key Trends and Drivers Summarized

How Is Assisted Reproductive Technology Transforming Modern Fertility Treatments?

Assisted Reproductive Technology (ART) has revolutionized the field of fertility treatments, offering hope to millions of individuals and couples struggling with infertility. ART encompasses a range of medical procedures used to treat infertility, with in vitro fertilization (IVF) being the most well-known and widely used method. These technologies involve the manipulation of eggs, sperm, or embryos to achieve pregnancy, and have opened up new possibilities for those facing challenges in conceiving naturally. ART has advanced significantly since its inception, with improvements in techniques such as intracytoplasmic sperm injection (ICSI), preimplantation genetic testing (PGT), and egg freezing, which have dramatically increased success rates and expanded the options available to patients. As ART becomes more sophisticated, it continues to push the boundaries of what is possible in reproductive medicine, providing personalized solutions that cater to the unique needs of each patient.

What Technological Innovations Are Enhancing the Success Rates of ART?

Technological innovations have played a critical role in enhancing the success rates of Assisted Reproductive Technology, making these treatments more accessible and effective. Advances in embryo culture techniques, such as time-lapse imaging and the use of artificial intelligence (AI) to assess embryo quality, have improved the ability to select the most viable embryos for transfer, increasing the likelihood of a successful pregnancy. The development of more refined hormonal stimulation protocols has also reduced the risk of ovarian hyperstimulation syndrome (OHSS) and improved outcomes for patients undergoing IVF. Additionally, innovations in cryopreservation, particularly vitrification, have significantly improved the survival rates of frozen eggs and embryos, allowing for more flexible treatment schedules and better preservation of reproductive potential. These technological advancements are not only boosting success rates but also making ART a more reliable option for a broader range of patients, including those with complex infertility issues or those who wish to delay childbearing.

What Market Trends Are Driving the Adoption of Assisted Reproductive Technology?

Several key market trends are driving the adoption of Assisted Reproductive Technology, reflecting broader changes in societal attitudes towards family planning and advancements in reproductive medicine. The increasing trend towards delayed parenthood, driven by career priorities and changing social norms, has led to a growing demand for fertility preservation options such as egg freezing, which is now often included as part of ART services. Additionally, the rising awareness and acceptance of ART among same-sex couples and single parents have expanded the market for fertility treatments, as these groups seek options to build their families. The growth of medical tourism, particularly in countries where ART is more affordable or where certain treatments are more readily available, is also contributing to the global expansion of ART services. Furthermore, the ongoing trend towards personalized medicine is influencing the ART market, as patients increasingly seek tailored treatment plans that align with their specific needs and circumstances.

What Factors Are Driving the Growth of the Assisted Reproductive Technology Market?

The growth in the Assisted Reproductive Technology market is driven by several factors that are reshaping the landscape of fertility treatments. A primary driver is the increasing prevalence of infertility, influenced by factors such as delayed childbearing, lifestyle changes, and environmental factors that impact reproductive health. Technological advancements in ART, including improvements in embryo selection, cryopreservation, and genetic testing, are enhancing success rates and broadening the appeal of these treatments to a wider range of patients. The expansion of ART services in emerging markets, where access to fertility treatments is becoming more widespread, is also contributing to market growth. Additionally, the rise in demand for fertility preservation options, driven by trends such as delayed parenthood and the desire for family planning flexibility, is boosting the adoption of ART. As these factors continue to evolve, the ART market is expected to experience sustained growth, driven by innovation, changing societal norms, and the increasing need for effective fertility solutions.

Select Competitors (Total 11 Featured) -

  • Bloom Fertility Centre
  • Cosmos Biomedical Ltd.
  • Cryolab Ltd.
  • European Sperm Bank ApS
  • Ferring Pharmaceuticals
  • Irvine Scientific
  • Microm UK Ltd
  • ORIGIO A/S
  • Ovascience Inc.
  • Parallabs Limited

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Assisted Reproductive Technology - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
    • Global Economic Update
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Infertility Rates Propel Growth in Assisted Reproductive Technology
    • Advancements in Embryo Selection Strengthen Business Case for ART
    • Increasing Demand for Egg Freezing Expands Addressable Market Opportunity
    • Shift Towards Delayed Parenthood Spurs Growth in Fertility Preservation Services
    • Growth in Same-Sex Couple Family Planning Drives Adoption of ART
    • Innovation in Genetic Testing Techniques Accelerates Demand for Tailored ART Solutions
    • Rising Acceptance of ART Among Single Parents Expands Market Reach
    • Global Medical Tourism Throws the Spotlight on Affordable ART Options
    • Improvement in Cryopreservation Techniques Sustains Growth in ART Market
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Fertility Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Fertility Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 3: World 16-Year Perspective for Fertility Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 6: World 16-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 7: World Assisted Reproductive Technology Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Assisted Reproductive Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Assisted Reproductive Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 10: World 16-Year Perspective for Assisted Reproductive Technology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for In-Vitro Fertilization (IVF) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 12: World Historic Review for In-Vitro Fertilization (IVF) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 13: World 16-Year Perspective for In-Vitro Fertilization (IVF) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Frozen Embryo Replacement (FER) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Frozen Embryo Replacement (FER) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 16: World 16-Year Perspective for Frozen Embryo Replacement (FER) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Artificial Insemination-Intrauterine Insemination (AI-IUI) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Artificial Insemination-Intrauterine Insemination (AI-IUI) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 19: World 16-Year Perspective for Artificial Insemination-Intrauterine Insemination (AI-IUI) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Other Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Other Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 22: World 16-Year Perspective for Other Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Fresh Non-Donor by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Fresh Non-Donor by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 25: World 16-Year Perspective for Fresh Non-Donor by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Frozen Non-Donor by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Frozen Non-Donor by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 28: World 16-Year Perspective for Frozen Non-Donor by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Embryo / Egg Banking by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Embryo / Egg Banking by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 31: World 16-Year Perspective for Embryo / Egg Banking by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Frozen Donor by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Frozen Donor by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 34: World 16-Year Perspective for Frozen Donor by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 35: World Recent Past, Current & Future Analysis for Fresh Donor by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 36: World Historic Review for Fresh Donor by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 37: World 16-Year Perspective for Fresh Donor by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 38: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 39: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 40: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Assisted Reproductive Technology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 41: USA Recent Past, Current & Future Analysis for Assisted Reproductive Technology by End-Use - Fertility Clinics, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 42: USA Historic Review for Assisted Reproductive Technology by End-Use - Fertility Clinics, Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 43: USA 16-Year Perspective for Assisted Reproductive Technology by End-Use - Percentage Breakdown of Value Sales for Fertility Clinics, Hospitals and Other End-Uses for the Years 2014, 2024 & 2030
    • TABLE 44: USA Recent Past, Current & Future Analysis for Assisted Reproductive Technology by Type - In-Vitro Fertilization (IVF), Frozen Embryo Replacement (FER), Artificial Insemination-Intrauterine Insemination (AI-IUI) and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 45: USA Historic Review for Assisted Reproductive Technology by Type - In-Vitro Fertilization (IVF), Frozen Embryo Replacement (FER), Artificial Insemination-Intrauterine Insemination (AI-IUI) and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 46: USA 16-Year Perspective for Assisted Reproductive Technology by Type - Percentage Breakdown of Value Sales for In-Vitro Fertilization (IVF), Frozen Embryo Replacement (FER), Artificial Insemination-Intrauterine Insemination (AI-IUI) and Other Types for the Years 2014, 2024 & 2030
    • TABLE 47: USA Recent Past, Current & Future Analysis for Assisted Reproductive Technology by Procedure - Fresh Non-Donor, Frozen Non-Donor, Embryo / Egg Banking, Frozen Donor and Fresh Donor - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 48: USA Historic Review for Assisted Reproductive Technology by Procedure - Fresh Non-Donor, Frozen Non-Donor, Embryo / Egg Banking, Frozen Donor and Fresh Donor Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 49: USA 16-Year Perspective for Assisted Reproductive Technology by Procedure - Percentage Breakdown of Value Sales for Fresh Non-Donor, Frozen Non-Donor, Embryo / Egg Banking, Frozen Donor and Fresh Donor for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 50: Canada Recent Past, Current & Future Analysis for Assisted Reproductive Technology by End-Use - Fertility Clinics, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Canada Historic Review for Assisted Reproductive Technology by End-Use - Fertility Clinics, Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 52: Canada 16-Year Perspective for Assisted Reproductive Technology by End-Use - Percentage Breakdown of Value Sales for Fertility Clinics, Hospitals and Other End-Uses for the Years 2014, 2024 & 2030
    • TABLE 53: Canada Recent Past, Current & Future Analysis for Assisted Reproductive Technology by Type - In-Vitro Fertilization (IVF), Frozen Embryo Replacement (FER), Artificial Insemination-Intrauterine Insemination (AI-IUI) and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 54: Canada Historic Review for Assisted Reproductive Technology by Type - In-Vitro Fertilization (IVF), Frozen Embryo Replacement (FER), Artificial Insemination-Intrauterine Insemination (AI-IUI) and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 55: Canada 16-Year Perspective for Assisted Reproductive Technology by Type - Percentage Breakdown of Value Sales for In-Vitro Fertilization (IVF), Frozen Embryo Replacement (FER), Artificial Insemination-Intrauterine Insemination (AI-IUI) and Other Types for the Years 2014, 2024 & 2030
    • TABLE 56: Canada Recent Past, Current & Future Analysis for Assisted Reproductive Technology by Procedure - Fresh Non-Donor, Frozen Non-Donor, Embryo / Egg Banking, Frozen Donor and Fresh Donor - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 57: Canada Historic Review for Assisted Reproductive Technology by Procedure - Fresh Non-Donor, Frozen Non-Donor, Embryo / Egg Banking, Frozen Donor and Fresh Donor Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 58: Canada 16-Year Perspective for Assisted Reproductive Technology by Procedure - Percentage Breakdown of Value Sales for Fresh Non-Donor, Frozen Non-Donor, Embryo / Egg Banking, Frozen Donor and Fresh Donor for the Years 2014, 2024 & 2030
  • JAPAN
    • Assisted Reproductive Technology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 59: Japan Recent Past, Current & Future Analysis for Assisted Reproductive Technology by End-Use - Fertility Clinics, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 60: Japan Historic Review for Assisted Reproductive Technology by End-Use - Fertility Clinics, Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 61: Japan 16-Year Perspective for Assisted Reproductive Technology by End-Use - Percentage Breakdown of Value Sales for Fertility Clinics, Hospitals and Other End-Uses for the Years 2014, 2024 & 2030
    • TABLE 62: Japan Recent Past, Current & Future Analysis for Assisted Reproductive Technology by Type - In-Vitro Fertilization (IVF), Frozen Embryo Replacement (FER), Artificial Insemination-Intrauterine Insemination (AI-IUI) and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 63: Japan Historic Review for Assisted Reproductive Technology by Type - In-Vitro Fertilization (IVF), Frozen Embryo Replacement (FER), Artificial Insemination-Intrauterine Insemination (AI-IUI) and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 64: Japan 16-Year Perspective for Assisted Reproductive Technology by Type - Percentage Breakdown of Value Sales for In-Vitro Fertilization (IVF), Frozen Embryo Replacement (FER), Artificial Insemination-Intrauterine Insemination (AI-IUI) and Other Types for the Years 2014, 2024 & 2030
    • TABLE 65: Japan Recent Past, Current & Future Analysis for Assisted Reproductive Technology by Procedure - Fresh Non-Donor, Frozen Non-Donor, Embryo / Egg Banking, Frozen Donor and Fresh Donor - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 66: Japan Historic Review for Assisted Reproductive Technology by Procedure - Fresh Non-Donor, Frozen Non-Donor, Embryo / Egg Banking, Frozen Donor and Fresh Donor Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 67: Japan 16-Year Perspective for Assisted Reproductive Technology by Procedure - Percentage Breakdown of Value Sales for Fresh Non-Donor, Frozen Non-Donor, Embryo / Egg Banking, Frozen Donor and Fresh Donor for the Years 2014, 2024 & 2030
  • CHINA
    • Assisted Reproductive Technology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 68: China Recent Past, Current & Future Analysis for Assisted Reproductive Technology by End-Use - Fertility Clinics, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 69: China Historic Review for Assisted Reproductive Technology by End-Use - Fertility Clinics, Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 70: China 16-Year Perspective for Assisted Reproductive Technology by End-Use - Percentage Breakdown of Value Sales for Fertility Clinics, Hospitals and Other End-Uses for the Years 2014, 2024 & 2030
    • TABLE 71: China Recent Past, Current & Future Analysis for Assisted Reproductive Technology by Type - In-Vitro Fertilization (IVF), Frozen Embryo Replacement (FER), Artificial Insemination-Intrauterine Insemination (AI-IUI) and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 72: China Historic Review for Assisted Reproductive Technology by Type - In-Vitro Fertilization (IVF), Frozen Embryo Replacement (FER), Artificial Insemination-Intrauterine Insemination (AI-IUI) and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 73: China 16-Year Perspective for Assisted Reproductive Technology by Type - Percentage Breakdown of Value Sales for In-Vitro Fertilization (IVF), Frozen Embryo Replacement (FER), Artificial Insemination-Intrauterine Insemination (AI-IUI) and Other Types for the Years 2014, 2024 & 2030
    • TABLE 74: China Recent Past, Current & Future Analysis for Assisted Reproductive Technology by Procedure - Fresh Non-Donor, Frozen Non-Donor, Embryo / Egg Banking, Frozen Donor and Fresh Donor - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 75: China Historic Review for Assisted Reproductive Technology by Procedure - Fresh Non-Donor, Frozen Non-Donor, Embryo / Egg Banking, Frozen Donor and Fresh Donor Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 76: China 16-Year Perspective for Assisted Reproductive Technology by Procedure - Percentage Breakdown of Value Sales for Fresh Non-Donor, Frozen Non-Donor, Embryo / Egg Banking, Frozen Donor and Fresh Donor for the Years 2014, 2024 & 2030
  • EUROPE
    • Assisted Reproductive Technology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 77: Europe Recent Past, Current & Future Analysis for Assisted Reproductive Technology by End-Use - Fertility Clinics, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 78: Europe Historic Review for Assisted Reproductive Technology by End-Use - Fertility Clinics, Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 79: Europe 16-Year Perspective for Assisted Reproductive Technology by End-Use - Percentage Breakdown of Value Sales for Fertility Clinics, Hospitals and Other End-Uses for the Years 2014, 2024 & 2030
    • TABLE 80: Europe Recent Past, Current & Future Analysis for Assisted Reproductive Technology by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 81: Europe Historic Review for Assisted Reproductive Technology by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 82: Europe 16-Year Perspective for Assisted Reproductive Technology by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 83: Europe Recent Past, Current & Future Analysis for Assisted Reproductive Technology by Type - In-Vitro Fertilization (IVF), Frozen Embryo Replacement (FER), Artificial Insemination-Intrauterine Insemination (AI-IUI) and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Europe Historic Review for Assisted Reproductive Technology by Type - In-Vitro Fertilization (IVF), Frozen Embryo Replacement (FER), Artificial Insemination-Intrauterine Insemination (AI-IUI) and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 85: Europe 16-Year Perspective for Assisted Reproductive Technology by Type - Percentage Breakdown of Value Sales for In-Vitro Fertilization (IVF), Frozen Embryo Replacement (FER), Artificial Insemination-Intrauterine Insemination (AI-IUI) and Other Types for the Years 2014, 2024 & 2030
    • TABLE 86: Europe Recent Past, Current & Future Analysis for Assisted Reproductive Technology by Procedure - Fresh Non-Donor, Frozen Non-Donor, Embryo / Egg Banking, Frozen Donor and Fresh Donor - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Europe Historic Review for Assisted Reproductive Technology by Procedure - Fresh Non-Donor, Frozen Non-Donor, Embryo / Egg Banking, Frozen Donor and Fresh Donor Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 88: Europe 16-Year Perspective for Assisted Reproductive Technology by Procedure - Percentage Breakdown of Value Sales for Fresh Non-Donor, Frozen Non-Donor, Embryo / Egg Banking, Frozen Donor and Fresh Donor for the Years 2014, 2024 & 2030
  • FRANCE
    • Assisted Reproductive Technology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 89: France Recent Past, Current & Future Analysis for Assisted Reproductive Technology by End-Use - Fertility Clinics, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 90: France Historic Review for Assisted Reproductive Technology by End-Use - Fertility Clinics, Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 91: France 16-Year Perspective for Assisted Reproductive Technology by End-Use - Percentage Breakdown of Value Sales for Fertility Clinics, Hospitals and Other End-Uses for the Years 2014, 2024 & 2030
    • TABLE 92: France Recent Past, Current & Future Analysis for Assisted Reproductive Technology by Type - In-Vitro Fertilization (IVF), Frozen Embryo Replacement (FER), Artificial Insemination-Intrauterine Insemination (AI-IUI) and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 93: France Historic Review for Assisted Reproductive Technology by Type - In-Vitro Fertilization (IVF), Frozen Embryo Replacement (FER), Artificial Insemination-Intrauterine Insemination (AI-IUI) and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 94: France 16-Year Perspective for Assisted Reproductive Technology by Type - Percentage Breakdown of Value Sales for In-Vitro Fertilization (IVF), Frozen Embryo Replacement (FER), Artificial Insemination-Intrauterine Insemination (AI-IUI) and Other Types for the Years 2014, 2024 & 2030
    • TABLE 95: France Recent Past, Current & Future Analysis for Assisted Reproductive Technology by Procedure - Fresh Non-Donor, Frozen Non-Donor, Embryo / Egg Banking, Frozen Donor and Fresh Donor - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 96: France Historic Review for Assisted Reproductive Technology by Procedure - Fresh Non-Donor, Frozen Non-Donor, Embryo / Egg Banking, Frozen Donor and Fresh Donor Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 97: France 16-Year Perspective for Assisted Reproductive Technology by Procedure - Percentage Breakdown of Value Sales for Fresh Non-Donor, Frozen Non-Donor, Embryo / Egg Banking, Frozen Donor and Fresh Donor for the Years 2014, 2024 & 2030
  • GERMANY
    • Assisted Reproductive Technology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 98: Germany Recent Past, Current & Future Analysis for Assisted Reproductive Technology by End-Use - Fertility Clinics, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Germany Historic Review for Assisted Reproductive Technology by End-Use - Fertility Clinics, Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 100: Germany 16-Year Perspective for Assisted Reproductive Technology by End-Use - Percentage Breakdown of Value Sales for Fertility Clinics, Hospitals and Other End-Uses for the Years 2014, 2024 & 2030
    • TABLE 101: Germany Recent Past, Current & Future Analysis for Assisted Reproductive Technology by Type - In-Vitro Fertilization (IVF), Frozen Embryo Replacement (FER), Artificial Insemination-Intrauterine Insemination (AI-IUI) and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Germany Historic Review for Assisted Reproductive Technology by Type - In-Vitro Fertilization (IVF), Frozen Embryo Replacement (FER), Artificial Insemination-Intrauterine Insemination (AI-IUI) and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 103: Germany 16-Year Perspective for Assisted Reproductive Technology by Type - Percentage Breakdown of Value Sales for In-Vitro Fertilization (IVF), Frozen Embryo Replacement (FER), Artificial Insemination-Intrauterine Insemination (AI-IUI) and Other Types for the Years 2014, 2024 & 2030
    • TABLE 104: Germany Recent Past, Current & Future Analysis for Assisted Reproductive Technology by Procedure - Fresh Non-Donor, Frozen Non-Donor, Embryo / Egg Banking, Frozen Donor and Fresh Donor - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 105: Germany Historic Review for Assisted Reproductive Technology by Procedure - Fresh Non-Donor, Frozen Non-Donor, Embryo / Egg Banking, Frozen Donor and Fresh Donor Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 106: Germany 16-Year Perspective for Assisted Reproductive Technology by Procedure - Percentage Breakdown of Value Sales for Fresh Non-Donor, Frozen Non-Donor, Embryo / Egg Banking, Frozen Donor and Fresh Donor for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 107: Italy Recent Past, Current & Future Analysis for Assisted Reproductive Technology by End-Use - Fertility Clinics, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 108: Italy Historic Review for Assisted Reproductive Technology by End-Use - Fertility Clinics, Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 109: Italy 16-Year Perspective for Assisted Reproductive Technology by End-Use - Percentage Breakdown of Value Sales for Fertility Clinics, Hospitals and Other End-Uses for the Years 2014, 2024 & 2030
    • TABLE 110: Italy Recent Past, Current & Future Analysis for Assisted Reproductive Technology by Type - In-Vitro Fertilization (IVF), Frozen Embryo Replacement (FER), Artificial Insemination-Intrauterine Insemination (AI-IUI) and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 111: Italy Historic Review for Assisted Reproductive Technology by Type - In-Vitro Fertilization (IVF), Frozen Embryo Replacement (FER), Artificial Insemination-Intrauterine Insemination (AI-IUI) and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 112: Italy 16-Year Perspective for Assisted Reproductive Technology by Type - Percentage Breakdown of Value Sales for In-Vitro Fertilization (IVF), Frozen Embryo Replacement (FER), Artificial Insemination-Intrauterine Insemination (AI-IUI) and Other Types for the Years 2014, 2024 & 2030
    • TABLE 113: Italy Recent Past, Current & Future Analysis for Assisted Reproductive Technology by Procedure - Fresh Non-Donor, Frozen Non-Donor, Embryo / Egg Banking, Frozen Donor and Fresh Donor - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 114: Italy Historic Review for Assisted Reproductive Technology by Procedure - Fresh Non-Donor, Frozen Non-Donor, Embryo / Egg Banking, Frozen Donor and Fresh Donor Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 115: Italy 16-Year Perspective for Assisted Reproductive Technology by Procedure - Percentage Breakdown of Value Sales for Fresh Non-Donor, Frozen Non-Donor, Embryo / Egg Banking, Frozen Donor and Fresh Donor for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Assisted Reproductive Technology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 116: UK Recent Past, Current & Future Analysis for Assisted Reproductive Technology by End-Use - Fertility Clinics, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 117: UK Historic Review for Assisted Reproductive Technology by End-Use - Fertility Clinics, Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 118: UK 16-Year Perspective for Assisted Reproductive Technology by End-Use - Percentage Breakdown of Value Sales for Fertility Clinics, Hospitals and Other End-Uses for the Years 2014, 2024 & 2030
    • TABLE 119: UK Recent Past, Current & Future Analysis for Assisted Reproductive Technology by Type - In-Vitro Fertilization (IVF), Frozen Embryo Replacement (FER), Artificial Insemination-Intrauterine Insemination (AI-IUI) and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 120: UK Historic Review for Assisted Reproductive Technology by Type - In-Vitro Fertilization (IVF), Frozen Embryo Replacement (FER), Artificial Insemination-Intrauterine Insemination (AI-IUI) and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 121: UK 16-Year Perspective for Assisted Reproductive Technology by Type - Percentage Breakdown of Value Sales for In-Vitro Fertilization (IVF), Frozen Embryo Replacement (FER), Artificial Insemination-Intrauterine Insemination (AI-IUI) and Other Types for the Years 2014, 2024 & 2030
    • TABLE 122: UK Recent Past, Current & Future Analysis for Assisted Reproductive Technology by Procedure - Fresh Non-Donor, Frozen Non-Donor, Embryo / Egg Banking, Frozen Donor and Fresh Donor - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 123: UK Historic Review for Assisted Reproductive Technology by Procedure - Fresh Non-Donor, Frozen Non-Donor, Embryo / Egg Banking, Frozen Donor and Fresh Donor Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 124: UK 16-Year Perspective for Assisted Reproductive Technology by Procedure - Percentage Breakdown of Value Sales for Fresh Non-Donor, Frozen Non-Donor, Embryo / Egg Banking, Frozen Donor and Fresh Donor for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 125: Rest of Europe Recent Past, Current & Future Analysis for Assisted Reproductive Technology by End-Use - Fertility Clinics, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 126: Rest of Europe Historic Review for Assisted Reproductive Technology by End-Use - Fertility Clinics, Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 127: Rest of Europe 16-Year Perspective for Assisted Reproductive Technology by End-Use - Percentage Breakdown of Value Sales for Fertility Clinics, Hospitals and Other End-Uses for the Years 2014, 2024 & 2030
    • TABLE 128: Rest of Europe Recent Past, Current & Future Analysis for Assisted Reproductive Technology by Type - In-Vitro Fertilization (IVF), Frozen Embryo Replacement (FER), Artificial Insemination-Intrauterine Insemination (AI-IUI) and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 129: Rest of Europe Historic Review for Assisted Reproductive Technology by Type - In-Vitro Fertilization (IVF), Frozen Embryo Replacement (FER), Artificial Insemination-Intrauterine Insemination (AI-IUI) and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 130: Rest of Europe 16-Year Perspective for Assisted Reproductive Technology by Type - Percentage Breakdown of Value Sales for In-Vitro Fertilization (IVF), Frozen Embryo Replacement (FER), Artificial Insemination-Intrauterine Insemination (AI-IUI) and Other Types for the Years 2014, 2024 & 2030
    • TABLE 131: Rest of Europe Recent Past, Current & Future Analysis for Assisted Reproductive Technology by Procedure - Fresh Non-Donor, Frozen Non-Donor, Embryo / Egg Banking, Frozen Donor and Fresh Donor - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 132: Rest of Europe Historic Review for Assisted Reproductive Technology by Procedure - Fresh Non-Donor, Frozen Non-Donor, Embryo / Egg Banking, Frozen Donor and Fresh Donor Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 133: Rest of Europe 16-Year Perspective for Assisted Reproductive Technology by Procedure - Percentage Breakdown of Value Sales for Fresh Non-Donor, Frozen Non-Donor, Embryo / Egg Banking, Frozen Donor and Fresh Donor for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Assisted Reproductive Technology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 134: Asia-Pacific Recent Past, Current & Future Analysis for Assisted Reproductive Technology by End-Use - Fertility Clinics, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 135: Asia-Pacific Historic Review for Assisted Reproductive Technology by End-Use - Fertility Clinics, Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 136: Asia-Pacific 16-Year Perspective for Assisted Reproductive Technology by End-Use - Percentage Breakdown of Value Sales for Fertility Clinics, Hospitals and Other End-Uses for the Years 2014, 2024 & 2030
    • TABLE 137: Asia-Pacific Recent Past, Current & Future Analysis for Assisted Reproductive Technology by Type - In-Vitro Fertilization (IVF), Frozen Embryo Replacement (FER), Artificial Insemination-Intrauterine Insemination (AI-IUI) and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 138: Asia-Pacific Historic Review for Assisted Reproductive Technology by Type - In-Vitro Fertilization (IVF), Frozen Embryo Replacement (FER), Artificial Insemination-Intrauterine Insemination (AI-IUI) and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 139: Asia-Pacific 16-Year Perspective for Assisted Reproductive Technology by Type - Percentage Breakdown of Value Sales for In-Vitro Fertilization (IVF), Frozen Embryo Replacement (FER), Artificial Insemination-Intrauterine Insemination (AI-IUI) and Other Types for the Years 2014, 2024 & 2030
    • TABLE 140: Asia-Pacific Recent Past, Current & Future Analysis for Assisted Reproductive Technology by Procedure - Fresh Non-Donor, Frozen Non-Donor, Embryo / Egg Banking, Frozen Donor and Fresh Donor - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 141: Asia-Pacific Historic Review for Assisted Reproductive Technology by Procedure - Fresh Non-Donor, Frozen Non-Donor, Embryo / Egg Banking, Frozen Donor and Fresh Donor Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 142: Asia-Pacific 16-Year Perspective for Assisted Reproductive Technology by Procedure - Percentage Breakdown of Value Sales for Fresh Non-Donor, Frozen Non-Donor, Embryo / Egg Banking, Frozen Donor and Fresh Donor for the Years 2014, 2024 & 2030
  • REST OF WORLD
    • TABLE 143: Rest of World Recent Past, Current & Future Analysis for Assisted Reproductive Technology by End-Use - Fertility Clinics, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 144: Rest of World Historic Review for Assisted Reproductive Technology by End-Use - Fertility Clinics, Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 145: Rest of World 16-Year Perspective for Assisted Reproductive Technology by End-Use - Percentage Breakdown of Value Sales for Fertility Clinics, Hospitals and Other End-Uses for the Years 2014, 2024 & 2030
    • TABLE 146: Rest of World Recent Past, Current & Future Analysis for Assisted Reproductive Technology by Type - In-Vitro Fertilization (IVF), Frozen Embryo Replacement (FER), Artificial Insemination-Intrauterine Insemination (AI-IUI) and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 147: Rest of World Historic Review for Assisted Reproductive Technology by Type - In-Vitro Fertilization (IVF), Frozen Embryo Replacement (FER), Artificial Insemination-Intrauterine Insemination (AI-IUI) and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 148: Rest of World 16-Year Perspective for Assisted Reproductive Technology by Type - Percentage Breakdown of Value Sales for In-Vitro Fertilization (IVF), Frozen Embryo Replacement (FER), Artificial Insemination-Intrauterine Insemination (AI-IUI) and Other Types for the Years 2014, 2024 & 2030
    • TABLE 149: Rest of World Recent Past, Current & Future Analysis for Assisted Reproductive Technology by Procedure - Fresh Non-Donor, Frozen Non-Donor, Embryo / Egg Banking, Frozen Donor and Fresh Donor - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 150: Rest of World Historic Review for Assisted Reproductive Technology by Procedure - Fresh Non-Donor, Frozen Non-Donor, Embryo / Egg Banking, Frozen Donor and Fresh Donor Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 151: Rest of World 16-Year Perspective for Assisted Reproductive Technology by Procedure - Percentage Breakdown of Value Sales for Fresh Non-Donor, Frozen Non-Donor, Embryo / Egg Banking, Frozen Donor and Fresh Donor for the Years 2014, 2024 & 2030

IV. COMPETITION